Transplant Surgery »  Faculty »  Ryutaro Hirose, M.D.
 
Division Programs
Dept. of Surgery Websites

Make a Gift

Support the Transplant Surgery Program in the quest to discover new treatments for diseases of the kidney, liver and pancreas and to improve transplantation outcomes.

Transplant Surgery »  Faculty »  Ryutaro Hirose, M.D.

Ryutaro Hirose, M.D.

Professor of Clinical Surgery
Division of Transplant Surgery
Associate Program Director,
UCSF General Surgery Residency Program

Contact Information

(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-8783 Academic
Ryutaro.Hirose@ucsfmedctr.org

Education

  • Columbia College, Columbia University, B.A., Mathematics, 1981-85
  • Columbia University College of Physicians And Surgeons, M.D., 1985-89

Residencies

  • University of California, San Francisco, Intern and Resident, Surgery, 1989-92
  • University of California, San Francisco, Resident, Surgery, 1995-96
  • University of California, San Francisco, Chief Resident, Surgery, 1996-97

Fellowships

  • University of California, San Francisco, Fellow, Transplant Surgery, 1997-99

Postdoctoral Training

  • University of California, San Francisco, Postdoctoral Fellow, Molecular Medicine, 1992-95

Board Certification

  • American Board of Surgery, 1998

Program Affiliations

Clinical Expertise

Research Interests

  • Ischemia Reperfusion Injury in Fatty Livers
  • Ischemia-reperfusion Injury in Kidneys and Hyperglycemia
  • Living Donor Liver Transplantation
  • Non-melanoma Skin Cancer in Organ Transplant Patients
  • Outcomes in Renal Transplant Recipients
  • Pathogenesis of Focal Segmental Glomerulosclerosis

Biography

Ryutaro Hirose is a Professor of Clinical Surgery at UCSF and performs liver, kidney and pancreas transplants. After graduating from Columbia College of Physicians and Surgeons, he completed his clinical and research training at UCSF as a resident in general surgery as well as a fellow in molecular medicine and transplantation surgery. His research interests include renal and hepatic ischemia - reperfusion injury, immune monitoring and skin cancer in transplant recipients. He has received funding from the NIH, NKF, UCSF, ASTS, and private industry. He is also actively involved with teaching students and residents. Dr. Hirose is currently the Associate Program Director for the General Surgery Residency at UCSF.

Research Summary

Dr. Hirose's research focus is ischemia-reperfusion injury and potential interventions to ameliorate renal and hepatic I-R injury. His group uses animal models, performs clinical and translational research as well as research on deceased donors. He collaborates with Dr. Claus Niemann, MD from the Dept. Anesthesia and they are co-Directors of the Ischemic Organ Injury Lab.

Selected Publications

  1. Validity of patient skin cancer report among organ transplant recipients.Dybbro E, Mihalis E, Hirose R, Arron ST. Clin Transplant. 2012 Mar 20
  2. Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial. Kelley RK, Hirose R, Venook AP. Liver Transpl. 2012 Mar 5.
  3. Intraoperative hyperglycemia augments ischemia reperfusion injury in renal transplantation: a prospective study. Parekh J, Niemann CU, Dang K, Hirose R.J Transplant. 2011;2011:652458
  4. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. Martinez-Palli G, Hirose R, Liu T, Xu F, Dang K, Feiner J, Serkova NJ, Niemann CU. Nephrol Dial Transplant. 2011 Jun;26(6):1813-20
  5. Hepatic surgery at a VA tertiary medical center: lessons learned. Alemi F, Kwon E, Freise C, Kang SM, Hirose R, Stewart L, Corvera CU. Am J Surg. 2010 Nov;200(5):591-5
  6. Induction of intestinal ischemia reperfusion injury by portal vein outflow occlusion in rats.Vincenti M, Behrends M, Dang K, Park YH, Hirose R, Blasi-Ibanez A, Liu T, Serkova NJ, Niemann CU. J Gastroenterol. 2010 Nov;45(11):1103-10

X